The effects of neoadjuvant anastrozole (arimidex) on tumor volume in postmenopausal women with breast cancer: A randomized, double-blind, single- center study

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2229-2235

  Dixon, J Michael ^a   Renshaw, Lorna ^a   Bellamy, Chris ^b   Stuart, Mary ^c   Hoctin Boes, Guido ^c   Miller, William R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOMAMMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MAMMOGRAPHY; MASTECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TUMOR VOLUME;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOADJUVANT THERAPY; NITRILES; POSTMENOPAUSE; RECEPTORS, ESTROGEN; TREATMENT OUTCOME; TRIAZOLES; ULTRASONOGRAPHY;

EID: 0034131068     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gelber, R. D., Goldhirsch, A., and Coates, A. S. Adjuvant therapy for breast cancer. Understanding the overview. J. Clin. Oncol., 11: 580-585, 1993.
2. Valero, V. Future direction of neoadjuvant therapy for breast cancer. Semin. Oncol., 25 (Suppl. 3): 36-41, 1998.
3. Bear, H. D. Indications for neoadjuvant chemotherapy for breast cancer. Semin. Oncol., 25 (Suppl. 3): 3-12, 1998.
4. Miller, W. R., Anderson, T. J., Hawkins, R. A., Keen, J., and Dixon, J. M. Neoadjuvant endocrine treatment: the Edinburgh experience. In: A. Howell and M. Dowsett (eds.), ESO Scientific Updates, Vol. 4, Primary Medical Therapy for Breast Cancer, pp. 1-11. Amsterdam: Elsevier Science BV, 1999.
5. Anderson, E. D. C., Forrest, A. P. M., Levack, P. A., Chetty, U., and Hawkins, R. A. Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer. Br. J. Cancer, 60: 223-226, 1989.
6. Leal da Silva, J. M., Cardosa, F., Oliveira, F., Cunha, H., and Pinto Ferreira, E. Neoadjuvant hormonal therapy in locally advanced breast cancer. Eur. J. Cancer, 34 (Suppl. 5): S15, 1998.
7. Valero, V., Hoff, P. M., Singletary, S. E., Buzdar, A. U., Theriault, R. L., Strom, E., Booser, D. J., Asmar, L., Frye, D., McNeese, M. D., and Hortobagyi, G. N. Combined modality treatment of locally advanced breast cancer (LABC) in elderly patients (PTS) using tamoxifen (TAM) as primary therapy. Proc. Am. Soc. Clin. Oncol., 17: 105a, 1989.
8. Keen, J. C., Dixon, J. M., Miller, E. P., Cameron, D. A., Chetty, U., Hanby, A., Bellamy, C., and Miller, W. R. The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer. Breast Cancer Res. Treat., 44: 123-133, 1997.
9. Geisler, J., King, N., Dowsett, M., Ottestad, L., Lundgren, S., Walton, P., Kormeset, P. O., and Lønning, P. E. Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer. Br. J. Cancer, 74: 1286-1291, 1996.
10. Buzdar, A. U., Jonat, W., Howell, A., Jones, S. E., Blomqvist, C. P., Vogel, C. L., Elermann, W., Wolter, J. M., Steinberg, M., Webster, A., and Lee, D., for the Arimidex Study Group. Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature Phase III trials. Cancer (Phila.), 83: 1142-1152, 1998.
11. Brodie, A. M. H., and Njar, V. C. O. Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications. J. Steroid Biochem. Mol. Biol., 66: 1-10, 1998.
12. McCarty, K. S., Jr., Millar, L. S., Cox, E. B., Konrath, J., and McCarty, K. S., Sr. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med., 709: 716-721, 1985.
13. Forouhi, P., Walsh, J. S., Anderson, T. J., and Chetty, U. Ultrasound as a method of measuring breast tumour size and monitoring response to primary systemic therapy. Br. J. Surgery, 81: 223-225, 1994.
14. Vinnicombe, S. J., MacVicar, A. D., Guy, R. L., Sloane, J. P., Powles, T. J., Knee, and G., Husband, J. E. Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology, 198: 333-340, 1996.
15. Dixon, J. M., Love, C. D. B., Tucker, S., Bellamy, D., Cameron, D., Miller, W. R., and Leonard, R. C. F. Letrozole as primary medical therapy for locally advanced and large operable breast cancer. Breast Cancer Res. Treat., 46: 54, 1997.
16. Fisher, B., Bryant, J., Wolmark, N., Mamounas, E., Brown, A., Fisher, E. R., Wickerham, D. L., Begovic, M., DeCillis, A., Robidoux, A., Margolese, R. G., Cruz, A. B., Jr., Hoehn, J. L., Lees, A. W., Dimitrov, N. V., and Bear, H. D. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J. Clin. Oncol., 16: 2672-2685, 1998.
17. Fornage, B. D., Toubas, O., and Morel, M. Clinical, mammographic, and sonographic determination of preoperative breast cancer size. Cancer (Phila.), 60: 765-771, 1987.
18. Pain, J. A., Ebbs, S. R., Hern, R. P., Lowe, S., and Bradbeer, J. W. Assessment of breast cancer size: a comparison of methods. Eur. J. Surg. Oncol., 18: 44-48, 1992.
19. Meden, H., Neues, K. P., Roben-Kampken, S., and Kuhn, W. A clinical, mammographic, sonographic and histologic evaluation of breast cancer. Int. J. Gynaecol. Obstet., 48: 193-199, 1995.
20. Zonderland, H. M., Coerkamp, E. G., Hermans, J., van de Vijver, M. J., and van de Voorthuisen, A. E. Diagnosis of breast cancer: contribution of US as an adjunct to mammography. Radiology, 213: 413-422, 1999.